204.89 0.00 (0.00%)
Pre-market: 8:43AM EST
|Bid||194.01 x 1100|
|Ask||206.95 x 1000|
|Day's range||202.06 - 206.99|
|52-week range||117.06 - 218.00|
|Beta (5Y monthly)||0.28|
|PE ratio (TTM)||30.18|
|Forward dividend & yield||3.40 (1.66%)|
|Ex-dividend date||11 Feb 2021|
|1y target est||N/A|
Lilly (LLY) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Eli Lilly (LLY) closed at $204.89 in the latest trading session, marking a +0.52% move from the prior day.
Shares of Rigel Pharmaceuticals (NASDAQ: RIGL) recently popped after the company announced a collaboration deal with one of America's largest drugmakers, Eli Lilly (NYSE: LLY). A new collaboration deal with a big pharmaceutical company isn't the only reason to keep an eye on this often overlooked biotech stock. Here's why investors can look forward to outstanding returns from Rigel Pharmaceuticals in the years to come.